US Pre-Market SEC Filings Roundup — January 14, 2026

15-01-2026

News Corp filed a Form 8-K on January 15, 2026 (AccNo: 0001564708-26-000010, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events or contents of the financial statements/exhibits are disclosed in the provided filing summary. All transaction values, financial metrics, and quantitative data are NOT_DISCLOSED.

15-01-2026

PAR Technology Corp filed a Form 8-K on January 15, 2026 (AccNo: 0000708821-26-000004), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific transaction details, dollar values, or financial impacts disclosed in the provided information. Sector not specified.

15-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002315, Size: 232 KB), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, dollar values, or quantitative results are provided in the filing summary. Sector is not specified.

15-01-2026

Compass Diversified Holdings filed a Form 8-K on January 15, 2026 (AccNo: 0001345126-26-000014, Size: 235 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

15-01-2026

Calavo Growers Inc filed a Form 8-K on 2026-01-15 (AccNo: 0001193125-26-013320, Size: 8 MB) reporting multiple items: Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, disclosures, transaction values, or financial metrics are provided in the event summary. This is a multi-item mandatory filing for material events.

15-01-2026

Matson, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001104659-26-003829, Size: 1 MB), disclosing results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or detailed results are provided in the filing summary. This appears to be a standard financial results announcement.

15-01-2026

Beyond Air, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002292, Size: 250 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial impacts, or exhibits are disclosed in the provided filing information. Sector is not specified.

15-01-2026

MacKenzie Realty Capital, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001550913-26-000006, Size: 330 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or exhibits are disclosed in the provided filing summary. Sector is not specified.

15-01-2026

Mission Produce, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001193125-26-013366, size: 8 MB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event from US SEC source, with sector not specified. No specific details on the agreement, transaction value, financial impacts, or other quantitative data are explicitly stated.

15-01-2026

Oncolytics Biotech Inc filed a Form 8-K on January 15, 2026 (AccNo: 0001104659-26-003815, Size: 219 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other event, financial statements, exhibits, transaction values, or quantitative impacts are disclosed in the provided filing summary. This is a multi-item filing with no information on timing compliance, core event, or materiality.

15-01-2026

Insteel Industries Inc filed a Form 8-K on January 15, 2026 (AccNo: 0001437749-26-001309, Size: 393 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, revenue, earnings, or other quantitative data are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure without detailed content provided.

15-01-2026

Signing Day Sports, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001213900-26-004431, Size: 678 KB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, or financial impacts are provided in the filing summary. Sector not specified.

15-01-2026

First Horizon Corp filed a Form 8-K on January 15, 2026 (AccNo: 0000036966-26-000012), reporting financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing focused on earnings release.

15-01-2026

Aspire Biopharma Holdings, Inc. disclosed an officer change via Form 8-K filed on January 15, 2026 (AccNo: 0001493152-26-002326, Size: 600 KB). The filing references Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, nature of change, reasons, or compensation are provided.

15-01-2026

ADVENT TECHNOLOGIES HOLDINGS, INC. filed a Form 8-K on January 15, 2026 (AccNo: 0001829126-26-000309, Size: 304 KB), reporting multiple items: Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers (Item 5.02), and Financial Statements and Exhibits (Item 9.01). This is a multi-item filing with no specific details on transaction values, parties, share counts, or financial impacts provided. All quantitative data and named entities beyond the filer are NOT_DISCLOSED.

15-01-2026

VAALCO Energy Inc./DE/ filed a Form 8-K on January 15, 2026 (AccNo: 0000894627-26-000002, Size: 236 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a financial results announcement. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.

15-01-2026

BlackRock, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001193125-26-013503, Size: 13 MB), disclosing financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned in the provided filing summary. This is a multi-item filing related to financial results announcement.

15-01-2026

Lumexa Imaging Holdings, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001193125-26-013511, size: 237 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or compensation were disclosed.

15-01-2026

Penumbra Inc filed a Form 8-K on January 15, 2026 (AccNo: 0000950103-26-000523, Size: 1 MB), reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, financial metrics, or other quantitative data are disclosed in the provided summary. This is a multi-item filing with sector not specified.

15-01-2026

Talen Energy Corp filed a Form 8-K on January 15, 2026 (AccNo: 0001622536-26-000004), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or quantitative impacts provided in the summary. Sector is not specified.

15-01-2026

Verano Holdings Corp. filed a Form 8-K on January 15, 2026 (AccNo: 0001628280-26-002111, Size: 243 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the transaction, dollar values, parties involved, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

15-01-2026

BITMINE IMMERSION TECHNOLOGIES, INC. filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002335, Size: 8 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other quantitative data are explicitly stated in the filing summary. All specific numbers, impacts, and contents are NOT_DISCLOSED.

15-01-2026

COMMUNITY FINANCIAL SYSTEM, INC. filed a Form 8-K on January 15, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Accession Number: 0001104659-26-003879. File size: 1 MB.

15-01-2026

Boston Scientific Corp filed a Form 8-K on January 15, 2026 (AccNo: 0000947871-26-000034, Size: 3 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific exhibits are provided in the filing summary. Sector not specified.

15-01-2026

Incannex Healthcare Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001213900-26-004488, Size: 222 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

15-01-2026

Goldman Sachs Group Inc filed a Form 8-K on January 15, 2026 (AccNo: 0000886982-26-000008, Size: 6 MB) reporting financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results announcement. No specific financial metrics, transaction values, or quantitative details are disclosed in the provided filing summary.

15-01-2026

Allstate Corp filed a Form 8-K on January 15, 2026 (AccNo: 0000899051-26-000009, Size: 329 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This indicates a voluntary disclosure of material nonpublic information to comply with Regulation FD, with attached exhibits. No specific details on the content of the disclosure or exhibits are provided.

15-01-2026

Profound Medical Corp. filed a Form 8-K on January 15, 2026 (AccNo: 0001171843-26-000273, Size: 226 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, named entities beyond the filer, or quantitative data are explicitly stated in the provided filing summary. All specific numbers, impacts, and further context are NOT_DISCLOSED.

15-01-2026

Soluna Holdings, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002337, Size: 296 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.

15-01-2026

Claritev Corp filed a Form 8-K on January 15, 2026 (AccNo: 0001793229-26-000005, Size: 3 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction values, financial metrics, or exhibits are provided in the filing summary. Sector is not specified.

15-01-2026

ConnectOne Bancorp, Inc. filed a Form 8-K on January 15, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The filing has Accession Number 0001437749-26-001311 and a size of 189 KB. No details on the specific event, transaction, financial statements, or exhibits are disclosed.

15-01-2026

Vail Resorts Inc filed a Form 8-K on January 15, 2026 (AccNo: 0000812011-26-000002, Size: 282 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the content of the Regulation FD disclosure or specific financial statements/exhibits are provided. No transaction values, financial metrics, or other quantitative data mentioned.

15-01-2026

FULLER H B CO filed a Form 8-K on January 15, 2026 (AccNo: 0001437749-26-001312, Size: 1 MB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

15-01-2026

Bank7 Corp. filed a Form 8-K on January 15, 2026 (AccNo: 0001140361-26-001264, size: 6 MB), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a financial results announcement, but no specific revenue, earnings, transaction values, or other numerical financial metrics are mentioned. Sector is not specified.

15-01-2026

Cumulus Media Inc filed a Form 8-K on January 15, 2026 (AccNo: 0001058623-26-000004, Size: 183 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected officer, reason for change, or compensation are disclosed.

15-01-2026

Morgan Stanley filed a Form 8-K on January 15, 2026 (AccNo: 0000895421-26-000007, Size: 7 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned.

15-01-2026

Strive, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001628280-26-002115, Size: 292 KB) reporting under Item 8.01 Other Events. No specific details on the core event, transaction, financial impacts, or quantitative metrics are disclosed in the provided filing summary. Sector is not specified.

15-01-2026

ImmunityBio, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001326110-26-000008, Size: 218 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results with attached statements and exhibits. No specific financial metrics, transaction values, or other numerical data are mentioned.

15-01-2026

GENERAL ELECTRIC CO filed an 8-K on January 15, 2026 (AccNo: 0000040545-26-000002, Size: 236 KB), reporting under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific names, transaction values, financial metrics, or further details are provided.

15-01-2026

Inception Growth Acquisition Ltd, a US-listed company, filed an 8-K on January 15, 2026 (AccNo: 0001213900-26-004495, Size: 263 KB), disclosing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific deal structure, parties, valuation, or financial terms are detailed in the provided filing summary. Sector is not specified.

15-01-2026

Philip Morris International Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001628280-26-002116, Size: 583 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no core event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.

15-01-2026

GBT Technologies Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001731122-26-000064), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) with exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or compensation provided in the available information. Sector not specified.

15-01-2026

Quantum Corp /DE/ filed an 8-K on January 15, 2026 (AccNo: 0001628280-26-002121, Size: 193 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure with no specific revenue, earnings, or transaction details provided in the summary. Sector not specified.

15-01-2026

Ocugen, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001104659-26-003900, Size: 7 MB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative financial metrics, transaction values, and strategic details are NOT_DISCLOSED.

15-01-2026

Beeline Holdings, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002341, Size: 259 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. Sector is not specified.

15-01-2026

Inuvo, Inc. filed a Form 8-K on 2026-01-15 reporting entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02. Item 9.01 includes financial statements and exhibits. No details on transaction terms, values, parties, or impacts are disclosed in the provided filing summary.